FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132953023> ?p ?o ?g. }

• W3132953023 abstract "Significance: Untreated methemoglobinemia may cause severe hypoxemia and even death when methemoglobin levels in the blood stream exceed 70%. Although CO-oximetry can be used to monitor the response to treatment for methemoglobinemia, it is costly and requires an invasive procedure for collecting blood samples from patients. A pulse CO-oximeter with a contact probe can be used to continuously and non-invasively measure the percentage of methemoglobin, as well as the percutaneous oxygen saturation. In terms of the prevention of infectious diseases, however, it is desirable to monitor methemoglobin and oxygen saturation levels in a non-contact manner. Diffuse reflectance spectral imaging is promising as a non-contact, non-invasive, and cost-effective clinical diagnostic tool for methemoglobinemia. Aim: To demonstrate the feasibility of visible spectral diffuse reflectance for in vivo monitoring of hemoglobin derivatives and evaluating methemoglobin production and reduction as well as hypoxemia during methemoglobinemia in rats. Approach: A new imaging approach based on the multiple regression analysis aided by Monte Carlo simulations for light transport was developed to quantify methemoglobin, oxygenated hemoglobin, and deoxygenated hemoglobin using a hyperspectral imaging system. An in vivo experiment with rats exposed to sodium nitrite (NaNO2) at different doses was performed to confirm the feasibility of the method for evaluating the dynamics of methemoglobin, oxygenated hemoglobin, and deoxygenated hemoglobin during methemoglobinemia. Systemic physiological parameters, including the percutaneous arterial oxygen saturation, heart rate (HR), and pulse distention, were measured by a commercially available pulse oximeter, and the results were compared to those obtained by the proposed method. Results: Both the methemoglobin concentration and methemoglobin saturation rapidly increased with a half-maximum time of <20 min. They reached their maximal values nearly 60 min after the administration of NaNO2. Tissue oxygen saturation dramatically dropped to a minimum of 33.7 % ± 0.4 % , 23.1 % ± 5.6 % , 8.8 % ± 1.7 % , and 9.7 % ± 5.1 % on average for NaNO2 doses of 25, 37.5, 50, and 75 mg/kg, respectively. Changes in methemoglobin concentration and tissue oxygen saturation are indicative of the temporary production of methemoglobin and severe hypoxemia during methemoglobinemia. Profound increases in the HR and pulse distention implied an elevated cardiac output caused by tachycardia and the resultant increase in peripheral blood volume to compensate for the hypoxia and hypoxemia during methemoglobinemia. This was in agreement with the time course of the peripheral hemoglobin volume concentration obtained by the proposed method. Conclusions: The proposed method is capable of the in vivo non-contact simultaneous evaluation of methemoglobin levels and hypoxemia during methemoglobinemia, and that it has potential as a tool for the diagnosis and management of methemoglobinemia." @default.
• W3132953023 created "2021-03-01" @default.
• W3132953023 creator A5035986648 @default.
• W3132953023 creator A5079834069 @default.
• W3132953023 creator A5089001158 @default.
• W3132953023 date "2021-02-13" @default.
• W3132953023 modified "2023-10-16" @default.
• W3132953023 title "Transcutaneous monitoring of hemoglobin derivatives during methemoglobinemia in rats using spectral diffuse reflectance" @default.
• W3132953023 cites W1978448435 @default.
• W3132953023 cites W1978636031 @default.
• W3132953023 cites W1979513581 @default.
• W3132953023 cites W1983436759 @default.
• W3132953023 cites W1990865456 @default.
• W3132953023 cites W2000386923 @default.
• W3132953023 cites W2001602838 @default.
• W3132953023 cites W2010216270 @default.
• W3132953023 cites W2010968771 @default.
• W3132953023 cites W2012728588 @default.
• W3132953023 cites W2013492930 @default.
• W3132953023 cites W2016761803 @default.
• W3132953023 cites W2022154442 @default.
• W3132953023 cites W2033247137 @default.
• W3132953023 cites W2034495440 @default.
• W3132953023 cites W2044607413 @default.
• W3132953023 cites W2059835776 @default.
• W3132953023 cites W2060120993 @default.
• W3132953023 cites W2065102252 @default.
• W3132953023 cites W2068254387 @default.
• W3132953023 cites W2077260085 @default.
• W3132953023 cites W2089724274 @default.
• W3132953023 cites W2096625632 @default.
• W3132953023 cites W2118746293 @default.
• W3132953023 cites W2119165072 @default.
• W3132953023 cites W2119811274 @default.
• W3132953023 cites W2132907499 @default.
• W3132953023 cites W2144196954 @default.
• W3132953023 cites W2154030730 @default.
• W3132953023 cites W2167437946 @default.
• W3132953023 cites W2177487400 @default.
• W3132953023 cites W2743681429 @default.
• W3132953023 cites W2911653367 @default.
• W3132953023 cites W2912288430 @default.
• W3132953023 cites W2980929900 @default.
• W3132953023 doi "https://doi.org/10.1117/1.jbo.26.3.033708" @default.
• W3132953023 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7881097" @default.
• W3132953023 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33583153" @default.
• W3132953023 hasPublicationYear "2021" @default.
• W3132953023 type Work @default.
• W3132953023 sameAs 3132953023 @default.
• W3132953023 citedByCount "4" @default.
• W3132953023 countsByYear W31329530232023 @default.
• W3132953023 crossrefType "journal-article" @default.
• W3132953023 hasAuthorship W3132953023A5035986648 @default.
• W3132953023 hasAuthorship W3132953023A5079834069 @default.
• W3132953023 hasAuthorship W3132953023A5089001158 @default.
• W3132953023 hasBestOaLocation W31329530231 @default.
• W3132953023 hasConcept C126322002 @default.
• W3132953023 hasConcept C136229726 @default.
• W3132953023 hasConcept C178790620 @default.
• W3132953023 hasConcept C185592680 @default.
• W3132953023 hasConcept C26865036 @default.
• W3132953023 hasConcept C2776779939 @default.
• W3132953023 hasConcept C2777737778 @default.
• W3132953023 hasConcept C2778917026 @default.
• W3132953023 hasConcept C2780124106 @default.
• W3132953023 hasConcept C2910876585 @default.
• W3132953023 hasConcept C42219234 @default.
• W3132953023 hasConcept C540031477 @default.
• W3132953023 hasConcept C71924100 @default.
• W3132953023 hasConcept C76538665 @default.
• W3132953023 hasConceptScore W3132953023C126322002 @default.
• W3132953023 hasConceptScore W3132953023C136229726 @default.
• W3132953023 hasConceptScore W3132953023C178790620 @default.
• W3132953023 hasConceptScore W3132953023C185592680 @default.
• W3132953023 hasConceptScore W3132953023C26865036 @default.
• W3132953023 hasConceptScore W3132953023C2776779939 @default.
• W3132953023 hasConceptScore W3132953023C2777737778 @default.
• W3132953023 hasConceptScore W3132953023C2778917026 @default.
• W3132953023 hasConceptScore W3132953023C2780124106 @default.
• W3132953023 hasConceptScore W3132953023C2910876585 @default.
• W3132953023 hasConceptScore W3132953023C42219234 @default.
• W3132953023 hasConceptScore W3132953023C540031477 @default.
• W3132953023 hasConceptScore W3132953023C71924100 @default.
• W3132953023 hasConceptScore W3132953023C76538665 @default.
• W3132953023 hasIssue "03" @default.
• W3132953023 hasLocation W31329530231 @default.
• W3132953023 hasLocation W31329530232 @default.
• W3132953023 hasLocation W31329530233 @default.
• W3132953023 hasOpenAccess W3132953023 @default.
• W3132953023 hasPrimaryLocation W31329530231 @default.
• W3132953023 hasRelatedWork W1517982398 @default.
• W3132953023 hasRelatedWork W2063313644 @default.
• W3132953023 hasRelatedWork W2085347117 @default.
• W3132953023 hasRelatedWork W2339360241 @default.
• W3132953023 hasRelatedWork W2402469293 @default.
• W3132953023 hasRelatedWork W3034370614 @default.
• W3132953023 hasRelatedWork W3128675354 @default.
• W3132953023 hasRelatedWork W3132953023 @default.
• W3132953023 hasRelatedWork W3184682556 @default.
• W3132953023 hasRelatedWork W2613647952 @default.

• next